BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4352060)

  • 1. Virogenic properties of AKR mouse sarcoma cells induced by rous sarcoma virus.
    Kuwata T; Okazaki T; Spahn GJ
    Arch Gesamte Virusforsch; 1973; 41(1):106-15. PubMed ID: 4352060
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfection of chicken fibroblasts with single exposure to DNA from virogenic mammalian cells.
    Svoboda J; Hlozánek I; Mach O; Michlová A; Rïman J; Urbánková M
    J Gen Virol; 1973 Oct; 21():47-55. PubMed ID: 4357377
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation of RSV rescue from RSV-transformed "poorly" virogenic cell lines by 5-bromodeoxyuridine treatment before fusion with chick embryo fibroblasts.
    Donner L; Sainerová H; Svoboda J; Scherneck S
    Int J Cancer; 1974 Jan; 13(1):37-42. PubMed ID: 4361916
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of oncogenic transformation by Rous sarcoma virus. I. Intracellular inactivation of cell-transforming ability of Rous sarcoma virus by 5-bromodeoxyuridine and light.
    Balduzzi P; Morgan HR
    J Virol; 1970 Apr; 5(4):470-7. PubMed ID: 4318089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth in spinner culture of AKR mouse cells, the K3b, induced by the Schmidt-Ruppin strain of Rous sarcoma virus.
    Okazaki T; Simizu B; Kuwata T
    Folia Biol (Praha); 1973; 19(4):293-5. PubMed ID: 4356559
    [No Abstract]   [Full Text] [Related]  

  • 6. Rous sarcoma virus-transformed hamster tumor cells resistant to 5-bromodeoxyuridine.
    Kuwata T; Morinaga N; Okazaki T; Ishitani R
    J Natl Cancer Inst; 1974 Jun; 52(6):1763-70. PubMed ID: 4365677
    [No Abstract]   [Full Text] [Related]  

  • 7. Malignant and transforming activity of Rous sarcoma virus. II. The study of variants of Rous sarcoma virus isolated from mouse tumours.
    Obukh IB; Kryukova IN
    Int J Cancer; 1969 Nov; 4(6):809-12. PubMed ID: 4314172
    [No Abstract]   [Full Text] [Related]  

  • 8. Rescue of rous sarcoma virus from rous sarcoma virus-transformed mammalian cells.
    Coffin JM
    J Virol; 1972 Jul; 10(1):153-6. PubMed ID: 4339192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of reciprocal changes in temperature on the transformed state of cells infected with a rous sarcoma virus mutant.
    Kawai S; Hanafusa H
    Virology; 1971 Nov; 46(2):470-9. PubMed ID: 4331732
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell transformation induced by Rous sarcoma virus: analysis of density dependence.
    Weiss RA
    Virology; 1971 Nov; 46(2):200-20. PubMed ID: 4331727
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation of a variant strain of Rous sarcoma virus oncogenic for ducks and mammals.
    Kuwata T; Kawakami H
    Arch Gesamte Virusforsch; 1970; 32(1):1-12. PubMed ID: 4321453
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic stability of the sarcoma viruses in murine and avian sarcoma virus-transformed nonproducer cells.
    Stephenson JR; Scolnick EM; Aaronson SA
    Int J Cancer; 1972 May; 9(3):577-83. PubMed ID: 4350125
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective lysis of cells transformed by Rous Sarcoma virus.
    Rifkin DB; Reich E
    Virology; 1971 Jul; 45(1):172-81. PubMed ID: 4329586
    [No Abstract]   [Full Text] [Related]  

  • 14. Integration of deoxyribonucleic acid specific for Rous sarcoma virus after infection of permissive and nonpermissive hosts.
    Varmus HE; Vogt PK; Bishop JM
    Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3067-71. PubMed ID: 4361674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Rous sarcoma virus with rat embryo fibroblasts of inbred Lewis strain in vitro.
    Veselý P; Donner L; Cinátl J; Sovová V
    Folia Biol (Praha); 1968; 14(6):457-65. PubMed ID: 4303535
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistence of Rous sarcoma virus in transformed non-permissive cells: characteristics of virus induction following Sendai virus-mediated fusion with permissive cells.
    Vigier P
    Int J Cancer; 1973 Mar; 11(2):473-83. PubMed ID: 4133581
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of rifampicin and a derivative on cells transformed by Rous sarcoma virus.
    Vaheri A; Hanafusa H
    Cancer Res; 1971 Dec; 31(12):2032-6. PubMed ID: 4330437
    [No Abstract]   [Full Text] [Related]  

  • 18. Rous sarcomas induced by heterotransplantation of virogenic rat tumour cells in mice.
    Bubeník J; Baresovà M; Micheel B; Sovová V; el-Ridi R; Keclíková M
    Int J Cancer; 1972 Nov; 10(3):527-38. PubMed ID: 4128687
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant and transforming activity of Rous sarcoma virus. I. Malignant effect of Rous sarcoma virus.
    Obukh IB; Kryukova IN; Biryulina TI; Kuznetsova NN
    Int J Cancer; 1969 Nov; 4(6):799-808. PubMed ID: 4314171
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of RSV-transformed "poorly" virogenic and non-virogenic mammalian cell lines with inhibitors of protein synthesis: failure to potentiate RSV rescue.
    Donner L; Sainerová H; Svoboda J; Turek L
    Folia Biol (Praha); 1975; 21(4):283-6. PubMed ID: 171178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.